Xbiotech Stock Market Value
| XBIT Stock | USD 7.61 0.26 3.54% |
| Symbol | XBiotech |
XBiotech Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XBiotech. If investors know XBiotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XBiotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Revenue Per Share 0.01 | Quarterly Revenue Growth (0.93) | Return On Assets (0.12) | Return On Equity (0.16) |
The market value of XBiotech is measured differently than its book value, which is the value of XBiotech that is recorded on the company's balance sheet. Investors also form their own opinion of XBiotech's value that differs from its market value or its book value, called intrinsic value, which is XBiotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XBiotech's market value can be influenced by many factors that don't directly affect XBiotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XBiotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if XBiotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XBiotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
XBiotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XBiotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XBiotech.
| 12/07/2023 |
| 12/01/2024 |
If you would invest 0.00 in XBiotech on December 7, 2023 and sell it all today you would earn a total of 0.00 from holding XBiotech or generate 0.0% return on investment in XBiotech over 360 days. XBiotech is related to or competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, and Enliven Therapeutics. XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for... More
XBiotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XBiotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XBiotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.26 | |||
| Information Ratio | 0.036 | |||
| Maximum Drawdown | 24.03 | |||
| Value At Risk | (7.91) | |||
| Potential Upside | 7.61 |
XBiotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for XBiotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XBiotech's standard deviation. In reality, there are many statistical measures that can use XBiotech historical prices to predict the future XBiotech's volatility.| Risk Adjusted Performance | 0.0579 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.50) | |||
| Sortino Ratio | 0.0327 | |||
| Treynor Ratio | 0.1016 |
XBiotech Backtested Returns
XBiotech appears to be slightly risky, given 3 months investment horizon. XBiotech shows Sharpe Ratio of 0.12, which attests that the company had a 0.12% return per unit of risk over the last 3 months. By examining XBiotech's technical indicators, you can evaluate if the expected return of 0.54% is justified by implied risk. Please utilize XBiotech's Downside Deviation of 5.26, mean deviation of 3.59, and Market Risk Adjusted Performance of 0.1116 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, XBiotech holds a performance score of 9. The firm maintains a market beta of 2.95, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, XBiotech will likely underperform. Please check XBiotech's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether XBiotech's historical returns will revert.
Auto-correlation | 0.67 |
Good predictability
XBiotech has good predictability. Overlapping area represents the amount of predictability between XBiotech time series from 7th of December 2023 to 4th of June 2024 and 4th of June 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XBiotech price movement. The serial correlation of 0.67 indicates that around 67.0% of current XBiotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.51 |
XBiotech lagged returns against current returns
Autocorrelation, which is XBiotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XBiotech's stock expected returns. We can calculate the autocorrelation of XBiotech returns to help us make a trade decision. For example, suppose you find that XBiotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
XBiotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XBiotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XBiotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XBiotech stock over time.
Current vs Lagged Prices |
| Timeline |
XBiotech Lagged Returns
When evaluating XBiotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XBiotech stock have on its future price. XBiotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XBiotech autocorrelation shows the relationship between XBiotech stock current value and its past values and can show if there is a momentum factor associated with investing in XBiotech.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.